Laurens F. Reeskamp

Evinacumab for Homozygous Familial Hypercholesterolemia

Frederick J. Raal, Robert S. Rosenson, Laurens F. Reeskamp et al. · New England Journal of Medicine · 2020 · 707 citations · Full text

Combination lipid-lowering therapy as first-line strategy in very high-risk patients

Kausik K. Ray, Laurens F. Reeskamp, Ulrich Laufs et al. · European Heart Journal · 2021 · 195 citations

Metabolic Syndrome, Lipid Disorder, Cardiovascular Disease +9

ANGPTL3 Inhibition With Evinacumab Results in Faster Clearance of IDL and LDL apoB in Patients With Homozygous Familial Hypercholesterolemia—Brief Report

Laurens F. Reeskamp, John S. Millar, WU Li-ya et al. · Arteriosclerosis Thrombosis and Vascular Biology · 2021 · 100 citations · Full text

Visual Language, Cardiovascular Disease, Graphic Design +12

Marked plaque regression in homozygous familial hypercholesterolemia

Laurens F. Reeskamp, Nick S. Nurmohamed, Michiel J. Bom et al. · Atherosclerosis · 2021 · 61 citations · Full text

Safety and efficacy of mipomersen in patients with heterozygous familial hypercholesterolemia

Laurens F. Reeskamp, John J.P. Kastelein, Patrick M. Moriarty et al. · Atherosclerosis · 2018 · 56 citations

Lipid Disorder, Heterozygous Familial Hypercholesterolemia, Cardiovascular Disease +5